Epigenetic Modifications in Cancer Development

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: closed (24 May 2024) | Viewed by 308

Special Issue Editor


E-Mail Website
Guest Editor
Institut Cochin, INSERM, U1016, CNRS, UMR8104, Université Paris Cité, 75014 Paris, France
Interests: epigenetics; DNA replication; cancer

Special Issue Information

Dear Colleagues,

It is now well known that epigenetic modifications (e.g., DNA methylation, histone modifications, histone variants, etc.) play a central role in cancer initiation and progression. These modifications regulate various essential cellular processes in cancer, including cell proliferation, apoptosis, invasion and migration. These modifications are also at the heart of cancer cell heterogeneity, cancer relapse and the emergence of treatment resistance. The characterization of these modifications, and of their functions, therefore enables us to improve patient diagnosis and envisage new therapeutic avenues. For this Special Issue, we welcome review articles and original research studies exploring these aspects. 

Dr. Benoit Miotto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epigenetics
  • cancer
  • histone
  • DNA methylation
  • cancer treatment
  • diagnosis
  • biomarkers
  • resistance to treatment
  • chromatin organization

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop